Your browser doesn't support javascript.
loading
Dysfunction of NaV1.4, a skeletal muscle voltage-gated sodium channel, in sudden infant death syndrome: a case-control study.
Männikkö, Roope; Wong, Leonie; Tester, David J; Thor, Michael G; Sud, Richa; Kullmann, Dimitri M; Sweeney, Mary G; Leu, Costin; Sisodiya, Sanjay M; FitzPatrick, David R; Evans, Margaret J; Jeffrey, Iona J M; Tfelt-Hansen, Jacob; Cohen, Marta C; Fleming, Peter J; Jaye, Amie; Simpson, Michael A; Ackerman, Michael J; Hanna, Michael G; Behr, Elijah R; Matthews, Emma.
Afiliação
  • Männikkö R; MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, University College London, London, UK.
  • Wong L; Cardiology Clinical Academic Group, St George's University of London and St George's University Hospitals NHS Foundation Trust, London, UK.
  • Tester DJ; Division of Heart Rhythm Services, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA; Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA; Windland Smith Rice Sudden Death Genomics Laboratory, Department of Molecular
  • Thor MG; MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, University College London, London, UK.
  • Sud R; Neurogenetics Unit, Institute of Neurology, University College London, London, UK.
  • Kullmann DM; MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, University College London, London, UK; Department of Clinical and Experimental Epilepsy, Institute of Neurology, University College London, London, UK.
  • Sweeney MG; Neurogenetics Unit, Institute of Neurology, University College London, London, UK.
  • Leu C; Department of Clinical and Experimental Epilepsy, Institute of Neurology, University College London, London, UK; Chalfont Centre for Epilepsy, Chalfont St Peter, UK.
  • Sisodiya SM; Department of Clinical and Experimental Epilepsy, Institute of Neurology, University College London, London, UK; Chalfont Centre for Epilepsy, Chalfont St Peter, UK.
  • FitzPatrick DR; MRC Human Genetics Unit, MRC Institute of Genetics & Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK.
  • Evans MJ; Department of Pathology, Royal Infirmary of Edinburgh, Edinburgh, UK.
  • Jeffrey IJM; Department of Pathology, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Tfelt-Hansen J; Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; Department of Forensic Medicine, Faculty of Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Medicine and Surgery, University of Copenhagen, Copenhagen, Denm
  • Cohen MC; Department of Histopathology, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
  • Fleming PJ; School of Social and Community Medicine, University of Bristol, Bristol, UK.
  • Jaye A; Department of Medical and Molecular Genetics, Faculty of Life Science and Medicine, King's College London, London, UK.
  • Simpson MA; Department of Medical and Molecular Genetics, Faculty of Life Science and Medicine, King's College London, London, UK.
  • Ackerman MJ; Division of Heart Rhythm Services, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA; Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA; Windland Smith Rice Sudden Death Genomics Laboratory, Department of Molecular
  • Hanna MG; MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, University College London, London, UK. Electronic address: m.hanna@ucl.ac.uk.
  • Behr ER; Cardiology Clinical Academic Group, St George's University of London and St George's University Hospitals NHS Foundation Trust, London, UK.
  • Matthews E; MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, University College London, London, UK.
Lancet ; 391(10129): 1483-1492, 2018 04 14.
Article em En | MEDLINE | ID: mdl-29605429
ABSTRACT

BACKGROUND:

Sudden infant death syndrome (SIDS) is the leading cause of post-neonatal infant death in high-income countries. Central respiratory system dysfunction seems to contribute to these deaths. Excitation that drives contraction of skeletal respiratory muscles is controlled by the sodium channel NaV1.4, which is encoded by the gene SCN4A. Variants in NaV1.4 that directly alter skeletal muscle excitability can cause myotonia, periodic paralysis, congenital myopathy, and myasthenic syndrome. SCN4A variants have also been found in infants with life-threatening apnoea and laryngospasm. We therefore hypothesised that rare, functionally disruptive SCN4A variants might be over-represented in infants who died from SIDS.

METHODS:

We did a case-control study, including two consecutive cohorts that included 278 SIDS cases of European ancestry and 729 ethnically matched controls without a history of cardiovascular, respiratory, or neurological disease. We compared the frequency of rare variants in SCN4A between groups (minor allele frequency <0·00005 in the Exome Aggregation Consortium). We assessed biophysical characterisation of the variant channels using a heterologous expression system.

FINDINGS:

Four (1·4%) of the 278 infants in the SIDS cohort had a rare functionally disruptive SCN4A variant compared with none (0%) of 729 ethnically matched controls (p=0·0057).

INTERPRETATION:

Rare SCN4A variants that directly alter NaV1.4 function occur in infants who had died from SIDS. These variants are predicted to significantly alter muscle membrane excitability and compromise respiratory and laryngeal function. These findings indicate that dysfunction of muscle sodium channels is a potentially modifiable risk factor in a subset of infant sudden deaths.

FUNDING:

UK Medical Research Council, the Wellcome Trust, National Institute for Health Research, the British Heart Foundation, Biotronik, Cardiac Risk in the Young, Higher Education Funding Council for England, Dravet Syndrome UK, the Epilepsy Society, the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health, and the Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Morte Súbita do Lactente / Músculo Esquelético / Canal de Sódio Disparado por Voltagem NAV1.4 / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Infant / Male Idioma: En Revista: Lancet Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Morte Súbita do Lactente / Músculo Esquelético / Canal de Sódio Disparado por Voltagem NAV1.4 / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Infant / Male Idioma: En Revista: Lancet Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido